Aavrh10-hsgsh Uses, Dosage, Side Effects and more
Aavrh10-hsgsh is under investigation in clinical trial NCT03612869 (Study of aavrh10-h.sgsh Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)).
| Attribute | Details |
|---|---|
| Trade Name | Aavrh10-hsgsh |
| Generic | Olenasufligene relduparvovec |
| Olenasufligene relduparvovec Other Names | Aavrh10-hsgsh, Dna (recombinant adeno-associated virus 2 vector lys-saf302 human n-sulfoglucosamine sulfohydrolase cdna-specifying), Olenasufligene relduparvovec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
